Part Number
Part Number:
NSN:
NIIN:
Item Name:
ERYTHROMYCIN DELAYED-RELEASE CAP
Definition:
CAGE Information
| Code | Company |
|---|---|
| 0SYT3 | MAJOR PHARMACEUTICALS INC |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
| SUPP | SUPPLEMENTARY FEATURES | MEDSEP ITEM FOR DOD,PARKE DAVIX |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ERYTHROMYCIN DELAYED-RELEASE CAPSULES USP 250MG 100S BT |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |